Who
Nina S. Kjellson
Director
Company insider
Files Form 4 as: Director, Eloxx Pharmaceuticals; Director, Tyra Biosciences; Director, Ocera Therapeutics; Director and 10% owner, Eiger BioPharmaceuticals; 10% owner, Glaukos; Director, Cidara Therapeutics; 10% owner, Marketo; Director and 10% owner, Trius Therapeutics.
In numbers
- Trades disclosed
- 89
- Buys
- 5
- Sells
- 14
- Bought
- $13.5M
- Sold
- $5.7M
- Companies
- 10
- Companies where not an officer
- 10
- First trade
- 6 Aug 2010
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,587 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,587 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $26K1,890 at $13.76 | filing |
| 5 Feb 2025filed 7 Feb 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $48K3,511 at $13.76 | filing |
| 23 Jan 2025filed 27 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $78K4,825 at $16.26 | filing |
| 21 Jan 2025filed 21 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $65K3,993 at $16.36 | filing |
| 17 Jan 2025filed 21 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $210K12,808 at $16.40 | filing |
| 17 Jan 2025filed 21 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $7,560461 at $16.40 | filing |
| 16 Jan 2025filed 21 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $113K6,944 at $16.29 | filing |
| 16 Jan 2025filed 21 Jan 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $14K835 at $16.29 | filing |
| 25 Nov 2024filed 26 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $79K4,706 at $16.84 | filing |
| 25 Nov 2024filed 26 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $9,531566 at $16.84 | filing |
| 7 Nov 2024filed 8 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $342K19,720 at $17.32 | filing |
| 7 Nov 2024filed 8 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $41K2,371 at $17.32 | filing |
| 6 Nov 2024filed 8 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $805K46,856 at $17.18 | filing |
| 6 Nov 2024filed 8 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $97K5,635 at $17.18 | filing |
| 5 Nov 2024filed 6 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $157K9,367 at $16.77 | filing |
| 5 Nov 2024filed 6 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $19K1,126 at $16.77 | filing |
| 4 Nov 2024filed 6 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $16K960 at $17.01 | filing |
| 4 Nov 2024filed 6 Nov 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $1,973116 at $17.01 | filing |
News
Tyra Biosciences (NASDAQ:TYRA) Stock Jumps 4.4% – Here's WhyTYRA · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Nina S. Kjellson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.